Pinz Capital Management, LP Catalent, Inc. Transaction History

Pinz Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $59,785 - $69,535	-500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $54,585 - $71,175	500 New	500 $67,000
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $3.11 Million - $3.96 Million	-42,800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $1.26 Million - $2.07 Million	-26,200 Reduced 37.97%	42,800 $3.14 Million
Q1 2020 May 12, 2020	BUY	$36.95 - $62.95 $2.51 Million - $4.27 Million	67,860 Added 5952.63%	69,000 $3.59 Million
Q4 2019 Feb 12, 2020	BUY	$47.06 - $56.64 $53,648 - $64,569	1,140 New	1,140 $64,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.